Remove services
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

Where electronic certificates produced and issued by the provincial application system are used, the provincial drug regulatory department shall clarify the relevant guidelines to enterprises within its administrative region and provide guidance and services. ” The requirements for providers (e.g.,

article thumbnail

FDA Oversight of AI Software Developed by Health Care Providers

Health Law Advisor

But the question is, to what extent do health care providers need to worry about FDA requirements as they use AI? FDA has been regulating machine learning algorithms used in a clinical context for decades. It’s important to understand that FDA regulation isn’t punitive in the sense that it’s only intended to apply to bad people.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. 117-164 ) (the “Act”)—an approximately $1.7

Medicaid 104
article thumbnail

President Signs FY 2022 Funding Bill into Law with 340B, Telehealth and Other Health Care Provisions

Hall Render

The measure includes funding for health care-related agencies, such as HHS, CMS, HRSA and the FDA, as well as several health care policy riders and provisions that address issues like 340B and telehealth waivers. An overview of the FY 2022 funding bill and a summary of its health care-related provisions can be found below.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

United States Department of Health and Human Services , 58 F.4th Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. 4th 696 (3d.

FDA 105
article thumbnail

Fourth Circuit Upholds Restrictions on Plaintiff Lawyer Advertising in West Virginia

Drug & Device Law

Lawyers, like professionals offering other services, can advertise and such advertising can serve the legitimate purpose of helping an individual determine if they have a legal problem and are in need of a lawyer. It’s harder still sometimes to differentiate between a lawyer ad and public service announcement. IMS Health Inc.,